Cytogenetic study of secondary malignancy in giant cell tumor
Taketsugu Fujibuchi(United States Bone and Joint Initiative), Hiroyuki Mukai, Seiichi Matsumoto(Fukuda Denshi (Japan)), Taisuke Tanizawa(Japanese Foundation For Cancer Research), Tabu Gokita, Keisuke Ae(The Cancer Institute Hospital), Noriko Motoi(Tokyo National Hospital), Takashi Shimoji(Japanese Foundation For Cancer Research), Keiko Hayakawa(Cancer Institute (WIA))
Cited by 2
Related Papers
Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: A hospital‐based study
|Cancer Science|2019|375
Clear Cell Sarcoma of Soft Tissue
|The American Journal of Surgical Pathology|2008|283
Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A
|Proceedings of the National Academy of Sciences|2018|264
Carbon Ion Radiation Therapy for Unresectable Sacral Chordoma: An Analysis of 188 Cases
|International Journal of Radiation Oncology*Biology*Physics|2016|182
Runx1 and Runx2 cooperate during sternal morphogenesis
|Development|2010|94